Neonatal Abstinence Syndrome | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Objectives: The prevalence of opioid use disorder (OUD) during pregnancy is increasing.
Practical recommendations will help providers treat pregnant women with OUD and reduce …

Importance Rising incidence of neonatal abstinence syndrome (NAS) is straining perinatal
care systems. Newborns with NAS traditionally receive care in neonatal intensive care units …

Neonatal abstinence syndrome (NAS) refers to a constellation of signs that are present in
some newborn infants resulting from the abrupt cessation of passive transfer of maternal …

Neonates exposed prenatally to opioids will often develop a collection of withdrawal signs
known as neonatal abstinence syndrome (NAS). The incidence of NAS has substantially …

Substance use during pregnancy is a critical public health issue that affects both the mother
and the fetus. While research has assessed racial differences in treatment completion …

Background Neonatal abstinence syndrome (NAS) includes an array of symptoms impacting
opioid-exposed newborns (OEN) owing to postnatal withdrawal from in utero substance …

Objectives To compare the duration of opioid treatment and length of stay among infants
treated for neonatal abstinence syndrome (NAS) by using a pilot buprenorphine vs …

Opioid abuse during pregnancy can result in Neonatal Opioid Withdrawal Syndrome
(NOWS). We investigated genome-wide methylation analyses of 96 placental tissue …

Stigma is a barrier to accessing care and treatment for perinatal women with pain and opioid
dependency, resulting in increased maternal/neonatal morbidity and mortality, prolonged …